Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US4330001060
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00Q53VYM7
HIMS
Hims & Hers Health Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Household & Personal Products · THEMEFOLIO: $HLTH
NAME
Hims & Hers Health Inc
ISIN
US4330001060
TICKER
HIMS
MIC
XNYS
REUTERS
HIMS.N
BLOOMBERG
HIMS US
Mon, 03.11.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a shareholder letter that is posted at investors.hims.com. “This quarter we continued to prove that our vision of helping tens of millions of...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.10.2025       Hims & Hers Health
US4330001060

NEW YORK, Oct. 29, 2025 /PRNewswire/ -- A securities fraud class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) is pending. The lawsuit was filed by Glancy Prongay & Murray LLP. Previous press releases stated incorrectly that Levi & Korsinsky filed the case. This press release makes that...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 15.10.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new specialty in women’s health, offering access to affordable treatment plans built specifically for women experiencing perimenopause and menopause. Starting today, women can work with a provider on the platform to access treatment...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 13.10.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2025 financial results after the market closes on Monday, November 3, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.10.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS) today published a new white paper - Understanding Hims & Hers Approach to Clinical Excellence, Quality, and Safety - detailing how rigorous standards, continuous monitoring, and customer-centered design are shaping the future of safe and effective telehealth. “At Hims & Hers, we believe that digi...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 03.10.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, Oct. 3, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) about an investigation into Hims & Hers' Board of Directors for potential breaches of fiduciary duties to...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 24.09.2025       Hims & Hers Health
US4330001060

NEW YORK, Sept. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Hims & Hers Health, Inc.  (NYSE: HIMS) breached their fiduciary duties to shareholders. ...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.09.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, Sept. 19, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) about an investigation into Hims & Hers' Board of Directors for potential breaches of fiduciary duties to the Company and its shareholder...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.09.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, Sept. 15, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) about an investigation into Hims & Hers' Board of Directors for potential breaches of fiduciary duties to the Company and its shareholder...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 10.09.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new category in men’s health, offering access to innovative, affordable, and personalized treatment plans for low testosterone. This press release features multimedia. View the full release here: https://www.businesswire.com/news/h...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 25.08.2025       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) and reminds investors of the August 25, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faru...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 25.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 25.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated ther...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 25.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sat, 23.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 23, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates in...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.08.2025       Hims & Hers Health
US4330001060

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased the Company’...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.08.2025       Hims & Hers Health
US4330001060

NEW ORLEANS, Aug. 22, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased the Company's securities betwe...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.08.2025       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wil...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.08.2025       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 22, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) on behalf of thos...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Fri, 22.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINIT...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS)....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.08.2025       Hims & Hers Health
US4330001060

  LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statemen...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.08.2025       Hims & Hers Health
US4330001060

SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, all dates inclusive (the "Class Period"), have until this Monday, August 25, 2025 to seek appointment as lead plaintiff of the Hims &...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated ther...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 20.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) have opportunity to lead the securities fraud class action lawsuit....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Wed, 20.08.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, Aug. 20, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). The firm is examining whether Hims & Hers, during the Class Period from April 29, 2025 through June 22...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINIT...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 18, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates in...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 18.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 18.08.2025       Hims & Hers Health
US4330001060

  LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statemen...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 18.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated ther...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sun, 17.08.2025       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 17, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) on behalf of thos...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sun, 17.08.2025       Hims & Hers Health
US4330001060

SAN DIEGO, Aug. 17, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, inclusive (the "Class Period"), have until Monday, August 25, 2025 to seek appointment as lead plaintiff of the Hims...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sat, 16.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sat, 16.08.2025       Hims & Hers Health
US4330001060

NEW YORK and NEW ORLEANS, Aug. 15, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. ("Hims" or the "C...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 15.08.2025       Hims & Hers Health
US4330001060

BENSALEM, Pa., Aug. 15, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS HEALTH, INC....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 15.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 15, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINIT...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 14.08.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, Aug. 14, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS)....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 14.08.2025       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wil...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 14.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 14, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 11.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Mon, 11.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Sat, 09.08.2025       Hims & Hers Health
US4330001060

NEW ORLEANS, Aug. 8, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased the Company's securities betwee...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 08.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 8, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inc...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 08.08.2025       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wil...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 08.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINITI...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Fri, 08.08.2025       Hims & Hers Health
US4330001060

SAN DIEGO, Aug. 8, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, both dates inclusive (the "Class Period"), have until Monday, August 25, 2025 to seek appointment as lead plaintiff of the Hims &...
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink
Thu, 07.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 7, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS)....
Read more
Hims & Hers Health
Technical Analysis Termsheets Terminal
Permalink